Back
Princeton Bancorp Vs. Keros Therapeutics Industry Stock Comparison
Sell
36
BPRN
Princeton Bancorp
Last Price:
30.84
Seasonality Move:
-0.05%
Sell
25
KROS
Keros Therapeutics
Last Price:
45.47
Seasonality Move:
4.22%
Sell
36
Princeton Bancorp (BPRN)
is a Sell
Is Princeton Bancorp a Buy, Sell or Hold?
- The current Princeton Bancorp [BPRN] share price is $30.60. The Score for BPRN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- BPRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPRN Stock Price Chart
What is Princeton Bancorp's stock price today?
-
The Princeton Bancorp share price today is $30.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
BPRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 53.2 | Buy |
Chaikin Money Flow: | 3469 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.15 - 30.81) | Buy |
Bollinger Bands (100): | (29.83 - 31.29) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.91 | Sell |
Relative Strength Index (14 RSI): | 36.74 | Sell |
Chaikin Money Flow: | -120480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.18 - 50.06) | Sell |
Bollinger Bands (100): | (50.42 - 64.92) | Sell |
BPRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.53 | Buy |
20-day SMA: | 30.39 | Buy |
50-day SMA: | 30.27 | Buy |
200-day SMA: | 31.43 | Sell |
8-day EMA: | 30.53 | Buy |
20-day EMA: | 30.45 | Buy |
50-day EMA: | 30.46 | Buy |
200-day EMA: | 30.94 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.5 | Sell |
20-day SMA: | 47.57 | Sell |
50-day SMA: | 52.43 | Sell |
200-day SMA: | 46.94 | Sell |
8-day EMA: | 46.46 | Sell |
20-day EMA: | 48 | Sell |
50-day EMA: | 51.59 | Sell |
200-day EMA: | 50.14 | Sell |
Princeton Bancorp Earnings Growth & BPRN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.58 per share, and an increase next year of $0.34 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Princeton Bancorp Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |